Skip to main content
Erschienen in: Endocrine 1/2017

30.03.2016 | Clinical Management of Endocrine Diseases

SIADH: differential diagnosis and clinical management

verfasst von: Alessandro Peri, Christian Grohé, Rossana Berardi, Isabelle Runkle

Erschienen in: Endocrine | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Despite the widespread prevalence of hyponatremia and its deleterious effects on patients, it is often overlooked and consequently undertreated. This set of four cases provides practical advice on how to identify, diagnose, and treat patients with syndrome of inappropriate antidiuretic hormone (SIADH). The first steps that a physician should take when diagnosing a patient with hyponatremia are to assess the severity of neurological symptoms, and check the patient’s volemic status in order to determine whether emergency treatment with hypertonic saline is indicated. Laboratory tests are necessary for the diagnosis of SIADH, but, in severe, symptomatic cases of hyponatremia, patients need treatment before the results of laboratory tests can be obtained. In this series, Case 1 demonstrates how awareness of hyponatremia led to early diagnosis and treatment. Case 2 demonstrates how multiple causes of hyponatremia can be diagnosed and managed sequentially. Case 3 illustrates how a patient with severe symptoms should be treated while waiting for laboratory test results to confirm diagnosis. Case 4 examines how the priorities of a patient should inform the management of their chronic SIADH, using palliative care of a patient with small-cell lung cancer as an example. There are several factors that clinicians should consider when making treatment decisions, including signs and symptoms, risks and benefits of different treatments, psychosocial factors, and the patient’s wishes. All the available treatment options have a place in the management of patients with SIADH, and a physician should individualize decisions based on a patient’s needs and priorities.
Literatur
1.
Zurück zum Zitat A. Upadhyay, B.L. Jaber, N.E. Madias, Incidence and prevalence of hyponatremia. Am. J. Med. 119, 30–35 (2006)CrossRef A. Upadhyay, B.L. Jaber, N.E. Madias, Incidence and prevalence of hyponatremia. Am. J. Med. 119, 30–35 (2006)CrossRef
3.
Zurück zum Zitat A. Peri, N. Pirozzi, G. Parenti, F. Festuccia, P. Menè, Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone. J. Endocrinol. Invest. 33, 671–682 (2010)CrossRefPubMed A. Peri, N. Pirozzi, G. Parenti, F. Festuccia, P. Menè, Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone. J. Endocrinol. Invest. 33, 671–682 (2010)CrossRefPubMed
4.
Zurück zum Zitat W. Fenske, S.K. Maier, A. Blechschmidt, B. Allolio, S. Störk, Utility and limitations of the traditional diagnostic approach to hyponatremia: a diagnostic study. Am. J. Med. 123, 652–657 (2010)CrossRefPubMed W. Fenske, S.K. Maier, A. Blechschmidt, B. Allolio, S. Störk, Utility and limitations of the traditional diagnostic approach to hyponatremia: a diagnostic study. Am. J. Med. 123, 652–657 (2010)CrossRefPubMed
5.
Zurück zum Zitat G. Corona, C. Giuliani, G. Parenti, D. Norello, J.G. Verbalis, G. Forti et al., Moderate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysis. PLoS One 8, e80451 (2013)CrossRefPubMedPubMedCentral G. Corona, C. Giuliani, G. Parenti, D. Norello, J.G. Verbalis, G. Forti et al., Moderate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysis. PLoS One 8, e80451 (2013)CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat L. Holland-Bill, C.F. Christiansen, U. Heide-Jørgensen, S.P. Ulrichsen, T. Ring, J.O. Jørgensen et al., Hyponatremia and mortality risk: a Danish cohort study of 279,508 acutely hospitalized patients. Eur. J. Endocrinol. 173, 71–81 (2015)CrossRefPubMed L. Holland-Bill, C.F. Christiansen, U. Heide-Jørgensen, S.P. Ulrichsen, T. Ring, J.O. Jørgensen et al., Hyponatremia and mortality risk: a Danish cohort study of 279,508 acutely hospitalized patients. Eur. J. Endocrinol. 173, 71–81 (2015)CrossRefPubMed
7.
Zurück zum Zitat R. Wald, B.L. Jaber, L.L. Price, A. Upadhyay, N.E. Madias, Impact of hospital-associated hyponatremia on selected outcomes. Arch. Intern. Med. 170, 294–302 (2010)CrossRefPubMed R. Wald, B.L. Jaber, L.L. Price, A. Upadhyay, N.E. Madias, Impact of hospital-associated hyponatremia on selected outcomes. Arch. Intern. Med. 170, 294–302 (2010)CrossRefPubMed
8.
Zurück zum Zitat K.M. Chow, B.C. Kwan, C.C. Szeto, Clinical studies of thiazide-induced hyponatremia. J. Natl Med. Assoc. 96, 1305–1308 (2004)PubMedPubMedCentral K.M. Chow, B.C. Kwan, C.C. Szeto, Clinical studies of thiazide-induced hyponatremia. J. Natl Med. Assoc. 96, 1305–1308 (2004)PubMedPubMedCentral
9.
Zurück zum Zitat G. Gill, B. Huda, A. Boyd, K. Skagen, D. Wile, I. Watson, C. van Heyningen, Characteristics and mortality of severe hyponatraemia—a hospital-based study. Clin. Endocrinol. (Oxf.) 65, 246–249 (2006)CrossRef G. Gill, B. Huda, A. Boyd, K. Skagen, D. Wile, I. Watson, C. van Heyningen, Characteristics and mortality of severe hyponatraemia—a hospital-based study. Clin. Endocrinol. (Oxf.) 65, 246–249 (2006)CrossRef
11.
Zurück zum Zitat E.J. Hoorn, J. Lindemans, R. Zietse, Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management. Nephrol. Dial. Transpl. 21, 70–76 (2006)CrossRef E.J. Hoorn, J. Lindemans, R. Zietse, Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management. Nephrol. Dial. Transpl. 21, 70–76 (2006)CrossRef
12.
Zurück zum Zitat E.J. Hoorn, P.M. Bouloux, V. Burst, Perspectives on the management of hyponatraemia secondary to SIADH across Europe. Best Pract. Res. Clin. Endocrinol. Metab. 26(Suppl 1), S27–S32 (2012)CrossRefPubMed E.J. Hoorn, P.M. Bouloux, V. Burst, Perspectives on the management of hyponatraemia secondary to SIADH across Europe. Best Pract. Res. Clin. Endocrinol. Metab. 26(Suppl 1), S27–S32 (2012)CrossRefPubMed
13.
Zurück zum Zitat M.S. Huda, A. Boyd, K. Skagen, D. Wile, C. van Heyningen, I. Watson et al., Investigation and management of severe hyponatraemia in a hospital setting. Postgrad. Med. J. 82, 216–219 (2006)CrossRefPubMedPubMedCentral M.S. Huda, A. Boyd, K. Skagen, D. Wile, C. van Heyningen, I. Watson et al., Investigation and management of severe hyponatraemia in a hospital setting. Postgrad. Med. J. 82, 216–219 (2006)CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat A. Greenberg, J.G. Verbalis, A.N. Amin, V.R. Burst, J.A. Chiodo 3rd, J.R. Chiong et al., Current treatment practice and outcomes. Report of the hyponatremia registry. Kidney Int. 88(1), 167–177 (2015)CrossRefPubMedPubMedCentral A. Greenberg, J.G. Verbalis, A.N. Amin, V.R. Burst, J.A. Chiodo 3rd, J.R. Chiong et al., Current treatment practice and outcomes. Report of the hyponatremia registry. Kidney Int. 88(1), 167–177 (2015)CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat G. Corona, C. Giuliani, J.G. Verbalis, G. Forti, M. Maggi, A. Peri, Hyponatremia improvement is associated with a reduced risk of mortality: evidence from a meta-analysis. PLoS One 10, e0124105 (2015)CrossRefPubMedPubMedCentral G. Corona, C. Giuliani, J.G. Verbalis, G. Forti, M. Maggi, A. Peri, Hyponatremia improvement is associated with a reduced risk of mortality: evidence from a meta-analysis. PLoS One 10, e0124105 (2015)CrossRefPubMedPubMedCentral
16.
17.
Zurück zum Zitat C. Giuliani, M. Cangioli, P. Beck-Peccoz, M. Faustini-Fustini, E. Fiaccadori, A. Peri, Awareness and management of hyponatraemia: the Italian Hyponatraemia Survey. J. Endocrinol. Invest. 36, 693–698 (2013)PubMed C. Giuliani, M. Cangioli, P. Beck-Peccoz, M. Faustini-Fustini, E. Fiaccadori, A. Peri, Awareness and management of hyponatraemia: the Italian Hyponatraemia Survey. J. Endocrinol. Invest. 36, 693–698 (2013)PubMed
18.
Zurück zum Zitat J.G. Verbalis, Managing hyponatremia in patients with syndrome of inappropriate antidiuretic hormone secretion. Endocrinol. Nutr. 57(Suppl 2), 30–40 (2010)CrossRefPubMed J.G. Verbalis, Managing hyponatremia in patients with syndrome of inappropriate antidiuretic hormone secretion. Endocrinol. Nutr. 57(Suppl 2), 30–40 (2010)CrossRefPubMed
19.
Zurück zum Zitat J.G. Verbalis, A. Grossman, C. Höybye, I. Runkle, Review and analysis of differing regulatory indications and expert panel guidelines for the treatment of hyponatremia. Curr. Med. Res. Opin. 30, 1201–1207 (2014)CrossRefPubMed J.G. Verbalis, A. Grossman, C. Höybye, I. Runkle, Review and analysis of differing regulatory indications and expert panel guidelines for the treatment of hyponatremia. Curr. Med. Res. Opin. 30, 1201–1207 (2014)CrossRefPubMed
20.
Zurück zum Zitat J.G. Verbalis, S.R. Goldsmith, A. Greenberg, C. Korzelius, R.W. Schrier, R.H. Sterns et al., Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am. J. Med. 126(10 Suppl 1), S1–S42 (2013)CrossRefPubMed J.G. Verbalis, S.R. Goldsmith, A. Greenberg, C. Korzelius, R.W. Schrier, R.H. Sterns et al., Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am. J. Med. 126(10 Suppl 1), S1–S42 (2013)CrossRefPubMed
21.
Zurück zum Zitat H. Furst, K.R. Hallows, J. Post, S. Chen, W. Kotzker, S. Goldfarb et al., The urine/plasma electrolyte ratio: a predictive guide to water restriction. Am. J. Med. Sci. 319, 240–244 (2000)CrossRefPubMed H. Furst, K.R. Hallows, J. Post, S. Chen, W. Kotzker, S. Goldfarb et al., The urine/plasma electrolyte ratio: a predictive guide to water restriction. Am. J. Med. Sci. 319, 240–244 (2000)CrossRefPubMed
22.
Zurück zum Zitat G. Decaux, C. Andres, F. Gankam Kengne, A. Soupart, Treatment of euvolemic hyponatremia in the intensive care unit by urea. Crit. Care 14, R184 (2010)CrossRefPubMedPubMedCentral G. Decaux, C. Andres, F. Gankam Kengne, A. Soupart, Treatment of euvolemic hyponatremia in the intensive care unit by urea. Crit. Care 14, R184 (2010)CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat R.F. Reeder, R.E. Harbaugh, Administration of intravenous urea and normal saline for the treatment of hyponatremia in neurosurgical patients. J. Neurosurg. 70, 201–206 (1989)CrossRefPubMed R.F. Reeder, R.E. Harbaugh, Administration of intravenous urea and normal saline for the treatment of hyponatremia in neurosurgical patients. J. Neurosurg. 70, 201–206 (1989)CrossRefPubMed
24.
Zurück zum Zitat G. Decaux, J. Unger, S. Brimioulle, J. Mockel, Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Rapid correction with urea, sodium chloride, and water restriction therapy. JAMA 247, 471–474 (1982)CrossRefPubMed G. Decaux, J. Unger, S. Brimioulle, J. Mockel, Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Rapid correction with urea, sodium chloride, and water restriction therapy. JAMA 247, 471–474 (1982)CrossRefPubMed
25.
Zurück zum Zitat J.E. Morley, Dehydration, hypernatremia, and hyponatremia. Clin. Geriatr. Med. 31, 389–399 (2015)CrossRefPubMed J.E. Morley, Dehydration, hypernatremia, and hyponatremia. Clin. Geriatr. Med. 31, 389–399 (2015)CrossRefPubMed
26.
Zurück zum Zitat W. Musch, G. Decaux, Treating the syndrome of inappropriate ADH secretion with isotonic saline. Q. J. Med. 91, 749–753 (1998)CrossRef W. Musch, G. Decaux, Treating the syndrome of inappropriate ADH secretion with isotonic saline. Q. J. Med. 91, 749–753 (1998)CrossRef
27.
Zurück zum Zitat T. Berl, F. Quittnat-Pelletier, J.G. Verbalis, R.W. Schrier, D.G. Bichet, J. Ouyang et al., Oral tolvaptan is safe and effective in chronic hyponatremia. J. Am. Soc. Nephrol. 21, 705–712 (2010)CrossRefPubMedPubMedCentral T. Berl, F. Quittnat-Pelletier, J.G. Verbalis, R.W. Schrier, D.G. Bichet, J. Ouyang et al., Oral tolvaptan is safe and effective in chronic hyponatremia. J. Am. Soc. Nephrol. 21, 705–712 (2010)CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat R.W. Schrier, P. Gross, M. Gheorghiade, T. Berl, J.G. Verbalis, F.S. Czerwiec et al., Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N. Engl. J. Med. 355, 2099–2112 (2006)CrossRefPubMed R.W. Schrier, P. Gross, M. Gheorghiade, T. Berl, J.G. Verbalis, F.S. Czerwiec et al., Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N. Engl. J. Med. 355, 2099–2112 (2006)CrossRefPubMed
29.
Zurück zum Zitat C. Grohé, R. Berardi, V. Burst, Hyponatraemia-SIADH in lung cancer diagnostic and treatment algorithms. Crit. Rev. Oncol. Hematol. 96(1), 1–8 (2015)CrossRefPubMed C. Grohé, R. Berardi, V. Burst, Hyponatraemia-SIADH in lung cancer diagnostic and treatment algorithms. Crit. Rev. Oncol. Hematol. 96(1), 1–8 (2015)CrossRefPubMed
Metadaten
Titel
SIADH: differential diagnosis and clinical management
verfasst von
Alessandro Peri
Christian Grohé
Rossana Berardi
Isabelle Runkle
Publikationsdatum
30.03.2016
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2017
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-0936-3

Weitere Artikel der Ausgabe 1/2017

Endocrine 1/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.